SHOULD ASYMPTOMATIC PROGRESSION FOLLOWING DEFINITIVE LOCAL TREATMENT FOR PROSTATE CANCER BE TREATED?
| Autor: | Ian M. Thompson, Patricia K. Lillis |
|---|---|
| Rok vydání: | 1996 |
| Předmět: |
Male
medicine.medical_specialty medicine.medical_treatment Urology Asymptomatic Prostate cancer Prostate medicine Humans Randomized Controlled Trials as Topic Prostatectomy business.industry Prostatic Neoplasms Hematology medicine.disease Combined Modality Therapy Surgery Radiation therapy Prostate-specific antigen Treatment Outcome medicine.anatomical_structure Oncology Practice Guidelines as Topic Disease Progression Hormonal therapy Adenocarcinoma Neoplasm Recurrence Local medicine.symptom business |
| Zdroj: | Hematology/Oncology Clinics of North America. 10:703-712 |
| ISSN: | 0889-8588 |
| Popis: | Asymptomatic progression following definitive therapy for prostate cancer can take the form of a detectable prostate-specific antigen (PSA) or local recurrence following radical prostatectomy or a rising PSA or palpable recurrence following radiotherapy. Options for treatment include hormonal therapy, radiotherapy, salvage surgery, and experimental therapies. Although such forms of treatment have known effects on intermediate endpoints, such as reduction of PSA, the overall effect on survival and quality of life is uncertain. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|